Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment

Interindividual Variability of Methadone Response

(2012) Yongfang Li et al.   Molecular Diagnosis & Therapy

Response to Methadone Maintenance Treatment is Associated with the MYOCD and GRM6 Genes

(2012) Francina Fonseca et al.   Molecular Diagnosis & Therapy

Nerve Growth Factor as a Signaling Molecule for Nerve Cells and also for the Neuroendocrine-Immune Systems

(2011) Marco Fiore et al.   REVIEWS IN THE NEUROSCIENCES

Dynamic association of p300 with the promoter of the G protein-coupled rat delta opioid receptor gene during NGF-induced neuronal differentiation

(2010) Yulong L. Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Nerve Growth Factor-Regulated Emergence of Functional  -Opioid Receptors

(2010) B. Bie et al.   JOURNAL OF NEUROSCIENCE

The genome-wide structure of the Jewish people

(2010) Doron M. Behar et al.   NATURE

A KCNJ6 (Kir3.2, GIRK2) gene polymorphism modulates opioid effects on analgesia and addiction but not on pupil size

(2010) Jörn Lötsch et al.   Pharmacogenetics and Genomics

Haploinsufficiency of the nerve growth factor beta gene in a 1p13 deleted female child with an insensitivity to pain

(2009) GREGORY J FITZGIBBON et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Polymorphism of human cytochrome P450 enzymes and its clinical impact

(2009) Shu-Feng Zhou et al.   DRUG METABOLISM REVIEWS

Heroin addiction in African Americans: a hypothesis-driven association study

(2009) O. Levran et al.   GENES BRAIN AND BEHAVIOR

Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution

(2009) Alexandra Doehring et al.   Pharmacogenetics and Genomics

A genome-wide genetic signature of Jewish ancestry perfectly separates individuals with and without full Jewish ancestry in a large random sample of European Americans

(2009) Anna C Need et al.   GENOME BIOLOGY

Addictions Biology: Haplotype-Based Analysis for 130 Candidate Genes on a Single Array

(2008) C. A. Hodgkinson et al.   ALCOHOL AND ALCOHOLISM

Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics: II. Ritonavir Effects on CYP3A and P-Glycoprotein Activities

(2008) ED Kharasch et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

BDNFvariability in opioid addicts and response to methadone treatment: preliminary findings

(2008) R. de Cid et al.   GENES BRAIN AND BEHAVIOR

Genetic susceptibility to heroin addiction: a candidate gene association study

(2008) O. Levran et al.   GENES BRAIN AND BEHAVIOR

ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence

(2008) Orna Levran et al.   HUMAN MOLECULAR GENETICS

Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders

(2008) Josep Maria Mercader et al.   HUMAN MOLECULAR GENETICS

Nerve growth factor R221W responsible for insensitivity to pain is defectively processed and accumulates as proNGF

(2008) Elin Larsson et al.   NEUROBIOLOGY OF DISEASE

Gender-dependent Association of a Functional NGF Polymorphism with Anxiety-related Personality Traits

(2008) U. Lang et al.   PHARMACOPSYCHIATRY

Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment

(2008) Séverine Crettol et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Role of the brain-derived neurotrophic factor at glutamatergic synapses

(2007) A L Carvalho et al.   BRITISH JOURNAL OF PHARMACOLOGY